These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 17186528

  • 21. Patient time costs associated with cancer care.
    Yabroff KR, Davis WW, Lamont EB, Fahey A, Topor M, Brown ML, Warren JL.
    J Natl Cancer Inst; 2007 Jan 03; 99(1):14-23. PubMed ID: 17202109
    [Abstract] [Full Text] [Related]

  • 22. Financial comparative analysis of minimally invasive surgery to open surgery for localized prostate cancer: a single-institution experience.
    Mouraviev V, Nosnik I, Sun L, Robertson CN, Walther P, Albala D, Moul JW, Polascik TJ.
    Urology; 2007 Feb 03; 69(2):311-4. PubMed ID: 17320670
    [Abstract] [Full Text] [Related]

  • 23. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ, Brawer MK, Barry MJ, Jones KM, Kwon Y, Gingrich JR, Aronson WJ, Nsouli I, Iyer P, Cartagena R, Snider G, Roehrborn C, Fox S.
    Contemp Clin Trials; 2009 Jan 03; 30(1):81-7. PubMed ID: 18783735
    [Abstract] [Full Text] [Related]

  • 24. A comparison of health care utilization and costs of children with and without autism spectrum disorders in a large group-model health plan.
    Croen LA, Najjar DV, Ray GT, Lotspeich L, Bernal P.
    Pediatrics; 2006 Oct 03; 118(4):e1203-11. PubMed ID: 17015508
    [Abstract] [Full Text] [Related]

  • 25. The Collection of Indirect and Nonmedical Direct Costs (COIN) form: a new tool for collecting the invisible costs of androgen independent prostate carcinoma.
    Sherman EJ, Pfister DG, Ruchlin HS, Rubin DM, Radzyner MH, Kelleher GH, Slovin SF, Kelly WK, Scher HI.
    Cancer; 2001 Feb 15; 91(4):841-53. PubMed ID: 11241254
    [Abstract] [Full Text] [Related]

  • 26. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
    Ghatnekar O, Alvegård T, Conradi N, Lenhoff S, Mellqvist UH, Persson U, Löthgren M.
    Clin Ther; 2008 Sep 15; 30(9):1704-13. PubMed ID: 18840377
    [Abstract] [Full Text] [Related]

  • 27. The economic burden of prostate cancer.
    Roehrborn CG, Black LK.
    BJU Int; 2011 Sep 15; 108(6):806-13. PubMed ID: 21884356
    [Abstract] [Full Text] [Related]

  • 28. Economic cost of community-acquired pneumonia in New Zealand adults.
    Scott G, Scott H, Turley M, Baker M.
    N Z Med J; 2004 Jun 18; 117(1196):U933. PubMed ID: 15280937
    [Abstract] [Full Text] [Related]

  • 29. Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000.
    Chang S, Long SR, Kutikova L, Bowman L, Finley D, Crown WH, Bennett CL.
    J Clin Oncol; 2004 Sep 01; 22(17):3524-30. PubMed ID: 15337801
    [Abstract] [Full Text] [Related]

  • 30. Contemporary trends in imaging test utilization for prostate cancer staging: data from the cancer of the prostate strategic urologic research endeavor.
    Cooperberg MR, Lubeck DP, Grossfeld GD, Mehta SS, Carroll PR.
    J Urol; 2002 Aug 01; 168(2):491-5. PubMed ID: 12131295
    [Abstract] [Full Text] [Related]

  • 31. Prostate brachytherapy: a descriptive analysis from CaPSURE.
    Lee WR, Sharkey J, Cowan JE, DuChane J, Carroll PR, CaPSURE Investigators.
    Brachytherapy; 2007 Aug 01; 6(2):123-8. PubMed ID: 17434105
    [Abstract] [Full Text] [Related]

  • 32. Cost comparison between watchful waiting with active surveillance and active treatment of clinically localized prostate cancer.
    Corcoran AT, Peele PB, Benoit RM.
    Urology; 2010 Sep 01; 76(3):703-7. PubMed ID: 20381846
    [Abstract] [Full Text] [Related]

  • 33. Direct medical cost of influenza-related hospitalizations in children.
    Keren R, Zaoutis TE, Saddlemire S, Luan XQ, Coffin SE.
    Pediatrics; 2006 Nov 01; 118(5):e1321-7. PubMed ID: 17079533
    [Abstract] [Full Text] [Related]

  • 34. The economic burden of prostate cancer survivorship care.
    Skolarus TA, Zhang Y, Miller DC, Wei JT, Hollenbeck BK.
    J Urol; 2010 Aug 01; 184(2):532-8. PubMed ID: 20620413
    [Abstract] [Full Text] [Related]

  • 35. Racial and ethnic variation in health resource use and cost for prostate cancer.
    Jayadevappa R, Malkowicz SB, Chhatre S, Gallo J, Schwartz JS.
    BJU Int; 2010 Sep 01; 106(6):801-8. PubMed ID: 20151963
    [Abstract] [Full Text] [Related]

  • 36. A comparison of health-care costs involved in treating people with and without Parkinson's disease in Southern Sydney, New South Wales, Australia.
    Cordato DJ, Schwartz R, Abbott E, Saunders R, Morfis L.
    J Clin Neurosci; 2006 Jul 01; 13(6):655-8. PubMed ID: 16797991
    [Abstract] [Full Text] [Related]

  • 37. Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes.
    Agarwal PK, Sadetsky N, Konety BR, Resnick MI, Carroll PR, Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE).
    Cancer; 2008 Jan 15; 112(2):307-14. PubMed ID: 18050294
    [Abstract] [Full Text] [Related]

  • 38. Patterns of primary and secondary therapy for prostate cancer in elderly men: analysis of data from CaPSURE.
    Konety BR, Cowan JE, Carroll PR, CaPSURE Investigators.
    J Urol; 2008 May 15; 179(5):1797-803; discussion 1803. PubMed ID: 18343440
    [Abstract] [Full Text] [Related]

  • 39. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.
    Paparel P, Cronin AM, Savage C, Scardino PT, Eastham JA.
    Eur Urol; 2009 Feb 15; 55(2):404-10. PubMed ID: 18639970
    [Abstract] [Full Text] [Related]

  • 40. The burden of illness associated with renal cell carcinoma in the United States.
    Lang K, Danchenko N, Gondek K, Schwartz B, Thompson D.
    Urol Oncol; 2007 Feb 15; 25(5):368-75. PubMed ID: 17826652
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.